HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.

AbstractOBJECTIVE:
To investigate liver fibrosis, TGF-?1 levels and curative effects on hepatocellular carcinoma (HCC) with small and conventional dose perfusion chemotherapy by transcatheter arterial chemo embolization (TACE).
METHODS:
Thirty-six hepatocellular carcinoma patients not indicated for surgical resection underwent super- selective transcatheter arterial chemoembolization, divided into small dose (n=15) and conventional dose (n=21) chemotherapy groups.
RESULTS:
With conventional doses, four indices of liver fibrosis focusing on hyaluronate acide (HA), human procollagen type-III (hPC-III), collagen type-IV (IV-C) and transforming growth factor-βl (TGF-β1) were obviously increased postoperative compared with preoperative (P<0.01); in contrast, with small doses there were no significant differences except for TGF-β1. Five year survival demonstrated no significant differences between the two groups (P>0.05).
CONCLUSION:
To hepatocellular carcinoma patients treated by TACE, reducing doses of chemotherapy drugs can reduce progress of liver fibrosis, without impacting on five year survival.
AuthorsHong Li, Yaohong Hu, Na Li, Yan Zhou
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 13 Issue 4 Pg. 1589-93 ( 2012) ISSN: 2476-762X [Electronic] Thailand
PMID22799372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Collagen Type III
  • Collagen Type IV
  • Laminin
  • Transforming Growth Factor beta1
  • Epirubicin
  • Mitomycin
  • Iodized Oil
  • Hyaluronic Acid
  • Fluorouracil
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
  • Carcinoma, Hepatocellular (therapy)
  • Chemoembolization, Therapeutic (adverse effects)
  • Chi-Square Distribution
  • Collagen Type III (blood)
  • Collagen Type IV (blood)
  • Epirubicin (administration & dosage)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Hyaluronic Acid (blood)
  • Iodized Oil (administration & dosage)
  • Kaplan-Meier Estimate
  • Laminin (blood)
  • Liver Cirrhosis (blood, chemically induced, prevention & control)
  • Liver Neoplasms (therapy)
  • Male
  • Mitomycin (administration & dosage)
  • Transforming Growth Factor beta1 (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: